MedPlus subsidiary Optival Health received a 5-day drug license suspension order from Odisha drug controller.
The suspension affects one store in Berhmpur for violations under Drugs and Cosmetics Rules, 1945.
The company estimates a potential revenue loss of ₹3.80 lakhs due to this suspension.
This regulatory disclosure was filed pursuant to SEBI Listing Regulations circular requirements.